Paul Tudor Jones Tudor Investment Corp
Paul Tudor Jones is the founder of Tudor Investment Corporation and a pioneering macro trader. He rose to prominence after navigating the 1987 market crash successfully and has since built a multi-strategy firm spanning global markets. Jones is widely associated with discretionary macro trading, risk management discipline, and high-profile philanthropic efforts in education and the environment.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Russell 2000 ETF
IWM
|
+$662M |
| 2 |
Invesco QQQ Trust
QQQ
|
+$116M |
| 3 |
Broadcom
AVGO
|
+$96.2M |
| 4 |
Walmart Inc
WMT
|
+$91.2M |
| 5 |
ITCI
Intra-Cellular Therapies Inc.
ITCI
|
+$77.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Bitcoin Trust
IBIT
|
+$175M |
| 2 |
State Street Energy Select Sector SPDR ETF
XLE
|
+$152M |
| 3 |
iShares Core S&P 500 ETF
IVV
|
+$149M |
| 4 |
INFN
Infinera Corporation Common Stock
INFN
|
+$108M |
| 5 |
iShares MSCI Emerging Markets ETF
EEM
|
+$70.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 5.92% |
| 2 | Financials | 4.33% |
| 3 | Healthcare | 3.85% |
| 4 | Consumer Discretionary | 3.59% |
| 5 | Industrials | 3.49% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
301
CALL
Targa Resources
TRGP
$64.1B
| $15M | 0.05% |
74,600
+8,400
| +13% | +$1.67M |
|
302
CALL
e.l.f. Beauty
ELF
$6.02B
| $14.9M | 0.05% |
238,000
+207,400
| +678% | +$18.1M |
|
303
Enova International
ENVA
$6.05B
| $14.9M | 0.05% |
154,748
+62,378
| +68% | +$6.42M |
|
304
TJX Companies
TJX
$155B
| $14.9M | 0.05% |
+122,000
| New | +$14.8M |
|
305
PUT
Ulta Beauty
ULTA
$22.4B
| $14.8M | 0.05% |
40,500
+27,900
| +221% | +$10.6M |
|
306
First Industrial Realty Trust
FR
$8.34B
| $14.8M | 0.05% |
275,009
+269,528
| +4,917% | +$14.6M |
|
307
CALL
T-Mobile US
TMUS
$196B
| $14.8M | 0.05% |
55,500
+26,400
| +91% | +$6.51M |
|
308
Palantir
PLTR
$432B
| $14.8M | 0.05% |
175,212
+149,191
| +573% | +$13.1M |
|
309
MSCI
MSCI
$41B
| $14.8M | 0.05% |
26,131
-24,140
| -48% | -$14M |
|
310
CALL
Vertiv
VRT
$101B
| $14.8M | 0.05% |
204,600
+168,700
| +470% | +$18M |
|
311
General Mills
GIS
$21.4B
| $14.7M | 0.05% |
245,359
+173,432
| +241% | +$10.4M |
|
312
PUT
Strategy Inc
MSTR
$47.4B
| $14.6M | 0.05% |
50,800
+26,000
| +105% | +$8.26M |
|
313
PUT
Moderna
MRNA
$57.9B
| $14.5M | 0.05% |
513,100
-44,600
| -8% | -$1.58M |
|
314
Biogen
BIIB
$32B
| $14.5M | 0.05% |
105,851
+83,848
| +381% | +$12M |
|
315
Netflix
NFLX
$331B
| $14.5M | 0.05% |
155,220
-309,620
| -67% | -$29.4M |
|
|
316
T-Mobile US
TMUS
$196B
| $14.4M | 0.05% |
54,105
+18,529
| +52% | +$4.57M |
|
317
SLB Ltd
SLB
$79.9B
| $14.4M | 0.05% |
343,899
-247,187
| -42% | -$10.1M |
|
318
CALL
Upstart Holdings
UPST
$2.95B
| $14.4M | 0.05% |
312,100
+284,900
| +1,047% | +$17.7M |
|
319
VF Corp
VFC
$5.65B
| $14.3M | 0.05% |
920,036
+866,555
| +1,620% | +$19.2M |
|
320
Selective Insurance
SIGI
$5.45B
| $14.2M | 0.05% |
155,335
+83,597
| +117% | +$7.33M |
|
321
GFL Environmental
GFL
$14.8B
| $14.2M | 0.05% |
294,175
+276,261
| +1,542% | +$12.5M |
|
322
Blackrock
BLK
$179B
| $14.2M | 0.05% |
+15,000
| New | +$14.7M |
|
323
Booz Allen Hamilton
BAH
$9.27B
| $14.2M | 0.05% |
+135,699
| New | +$16.4M |
|
324
DT Midstream
DTM
$12.9B
| $14.2M | 0.05% |
+146,985
| New | +$14.7M |
|
325
PUT
GE Vernova
GEV
$255B
| $14.2M | 0.05% |
46,400
+40,400
| +673% | +$14.1M |
|
Similar funds
Paul Tudor Jones's Q1 2025 Portfolio in Review
As of Q1 2025, Paul Tudor Jones held 3,818 positions worth $30.1B, up 15% from $26.3B the previous quarter. Its ten largest holdings account for 40% of the portfolio.
Paul Tudor Jones deployed $6.13B of net new capital in Q1 2025, opening 874 new positions and adding to 1,161 existing holdings. Its largest new stake was Intra-Cellular Therapies Inc.: 621,815 shares worth $82M.
By sector, the portfolio is most concentrated in Technology at 5.9% of assets, down from 6.4% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was iShares Bitcoin Trust, an estimated $175M trimmed.
- Paul Tudor Jones's largest Q1 2025 buy was Intra-Cellular Therapies Inc.: 621,815 shares worth $82M.
- Paul Tudor Jones added most to iShares Russell 2000 ETF in Q1 2025, an estimated $662M increase.
- Paul Tudor Jones's biggest Q1 2025 reduction was iShares Bitcoin Trust, cutting an estimated $175M.
- Paul Tudor Jones fully exited Infinera Corporation Common Stock in Q1 2025, selling an estimated $108M.
- Paul Tudor Jones's ten largest holdings make up 40% of its $30.1B portfolio in Q1 2025.
- Paul Tudor Jones opened 874 new positions and closed 844 in Q1 2025.
- Paul Tudor Jones's portfolio value rose 15% quarter-over-quarter to $30.1B.
Based on Tudor Investment Corp's 13F filing for Q1 2025, filed 15 May 2025.